Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              A Novel Neuroimaging Study for Painful Trigeminal Neuropathy

              Author:Heffernan, Megan   Alshelh, Zeynab   Chen, You-Chia   Schnieders, Jack   Kim, Minhae   Edwards, Robert   Loggia, Marco   Cheng, Hsinlin   

              Session Name:P4: Pain 1  

              Topic:Pain  

              Program Number:P4.004  

              Author Institution:Massachusettes General Hospital, Boston, MA  Massachusetts General Hospital, St Louis, MO  Massachusetts General Hospital, Boston, MA  

              Comparative Effectiveness of Troriluzole Versus Untreated Natural History Cohorts in Spinocerebellar Ataxia Leveraging Propensity Score Matching Methods

              Author:L'Italien, Gilbert   Potashman, Michele   Beiner, Melissa   Rogula, Basia   Powell, Lauren   Wirtz, Victoria   Stock, David   Qureshi, Irfan   Kuo, Sheng-Han   Rosenthal, Liana   Perlman, Susan   Coric, Vlad   Schmahmann, Jeremy   

              Session Name:P6: Movement Disorders: Ataxia 1  

              Topic:Movement Disorders  

              Program Number:P6.012  

              Author Institution:Biohaven Pharmaceuticals, New Haven, CT  Broadstreet HEOR, Vancouver, BC, Canada  Columbia University, New York, NY  Johns Hopkins School of Medicine, Lutherville, MD  UCLA School of Medicine, Los Angeles, CA  Massachusettes General Hospital, Boston, MA  

              Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA)

              Author:Potashman, Michele   Rogula, Basia   Powell, Lauren   Korol, Ellen   Dickson, Samuel   Hendrix, Suzanne   Heinrich, Maggie   Rudell, Katja   Abetz Webb, Linda   Beiner, Melissa   Coric, Vlad   Rosenthal, Liana   Perlman, Susan   Schmahmann, Jeremy   L'Italien, Gilbert   

              Session Name:P12: Movement Disorders: Ataxia 2  

              Topic:Movement Disorders  

              Program Number:P12.028  

              Author Institution:Biohaven Pharmaceuticals, New Haven, CT  Broadstreet HEOR, Vancouver, BC, Canada  Pentara Corporation, Millcreek, UT  Parexel International, London, United Kingdom  Patient-Centered Outcomes Assessments, Bollington, United Kingdom  Johns Hopkins School of Medicine, Lutherville, MD  UCLA School of Medicine, Los Angeles, CA  Massachusettes General Hospital, Boston, MA